Pier Paolo Pandolfi

Pier Paolo Pandolfi is an Italian doctor, geneticist, molecular biologist, and cancer researcher.

Pier Paolo Pandolfi
Born
Italy
NationalityItalian
Alma materUniversity of Perugia, Italy
Scientific career
Fields
Institutions
Websitepandolfilab.org

Originally from Rome, Italy, Pandolfi studied medicine at the University of Perugia in Umbria in central Italy, where he began his research into acute promyelocytic leukemia.[1][2] He received his MD in 1989, his Ph.D. in 1995, and did postgraduate work at the Royal Postgraduate Medical School.[2] In 1994, Pandolfi moved his research to the Memorial Sloan-Kettering Cancer Center in New York City and joined the faculty of Weill Cornell Graduate School of Medical Sciences as a professor of molecular biology, pathology, and human genetics.[1] Pandolfi eventually became the chair of cancer biology and genetics and the head of the molecular and developmental biology lab at Sloan-Kettering.[1]

Pandolfi left Sloan-Kettering in 2007 to become the director of Beth Israel Deaconess Medical Center (BIDMC)'s new cancer genetics program.[1] [3] While at BIDMC, Pandolfi was the George C. Reisman professor of medicine at Harvard Medical School and an associate member of the Broad Institute of MIT and Harvard University.[4][5] He became the director of the BIDMC Cancer Center and Cancer Research Institute in 2013.[4][6] Pandolfi received the Pezcoller Foundation-American Association for Cancer Research International Award for Cancer Research in 2011 and was elected as an Fellow of the American Association for the Advancement of Science in 2017 in recognition of his cancer research.[4][7]

Between fall 2018 and spring 2019, Pandofi pursued an inappropriate relationship with a postdoctoral researcher.[8] A Harvard internal investigation referred him to an external evaluation service that allowed him to return to work.[8] In December 2019, Pandolfi resigned from Harvard.[8] In May 2020, he became the director of the Institute of Cancer at Renown Health, joined the faculty of the Desert Research Institute, and was announced as the scientific director of the Veneto Institute of Molecular Medicine (VIMM) in Padua, Italy.[8][2] The VIMM scientific advisory board resigned in protest because they had not been consulted before Pandolfi's appointment.[8] The VIMM foundation reversed their decision to appoint Pandolfi in June 2020, and he resigned from his position at the Desert Research institute.[8]

References
  1. Gewin, Virginia (May 9, 2007). "Pier Paolo Pandolfi, Director, Cancer Genetics Programme, Beth Israel Deaconess Medical Center, Harvard University". Nature. 447 (7141): 228. doi:10.1038/nj7141-228a. ISSN 0028-0836. Retrieved October 13, 2020.
  2. "People: Dr. Pier Paolo Pandolfi joins Renown, Desert Research Institute". Northern Nevada Business Weekly. June 12, 2020. Archived from the original on October 18, 2020. Retrieved October 13, 2020.
  3. Allen, Scott (February 16, 2007). "Beth Israel Deaconess lures hot-shot cancer geneticist". Boston Globe. Archived from the original on February 23, 2019.
  4. Prescott, Bonnie (October 8, 2013). "Pier Paolo Pandolfi MD, PHD, to Head Cancer Center at Beth Israel Deaconess Medical Center". Beth Israel Deaconess Medical Center. Archived from the original on March 17, 2017.
  5. "Our faculty: Associate and affiliate members". Broad Institute. Archived from the original on March 17, 2017. Retrieved October 13, 2020.
  6. Kolata, Gina (January 16, 2018). "High-Fat Diet May Fuel Spread of Prostate Cancer". The New York Times. Archived from the original on February 22, 2019. Retrieved February 22, 2019.
  7. Herbert, Teresa (November 20, 2017). "Pier Paolo Pandolfi named AAAS 2017 fellow". Beth Israel Deaconess Medical Center. Archived from the original on July 19, 2020. Retrieved October 13, 2020.
  8. Abbott, Alison (July 2, 2020). "Former Harvard researcher who sexually harassed postdoc sparks turmoil at Italian institute". Nature. 583 (7815): 182–182. doi:10.1038/d41586-020-01987-1. ISSN 0028-0836.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.